Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Atishoo! Atishoo! we all fall down!

Carey BJ.

Age Ageing. 2006 Jul;35(4):446-7.

PMID:
16788083
2.
3.

The potential systemic effect of topically applied beta-blockers in glaucoma therapy.

Taniguchi T, Kitazawa Y.

Curr Opin Ophthalmol. 1997 Apr;8(2):55-8. Review.

PMID:
10168358
4.

Cardiac safety of ophthalmic timolol.

Mäenpää J, Pelkonen O.

Expert Opin Drug Saf. 2016 Nov;15(11):1549-1561. Epub 2016 Aug 31. Review.

PMID:
27534869
5.

Swallow syncope associated with complete atrioventricular block: a case report and review of the literature.

Elam MP, Laird JR, Johnson S, Stratton JR.

Mil Med. 1989 Sep;154(9):465-6. Review.

PMID:
2507966
6.

[Intermittent atrioventricular block in an accessory pathway associated with complete infrahissian block].

Palanca V, Quesada A, Roda J, Villalba S, Mihi N, Velasco J.

Rev Esp Cardiol. 2004 Apr;57(4):363-6. Review. Spanish.

7.

Systemic side effects associated with the ophthalmic administration of timolol.

Munroe WP, Rindone JP, Kershner RM.

Drug Intell Clin Pharm. 1985 Feb;19(2):85-9. Review.

PMID:
3882377
8.

[Complete heart block and Lyme disease: report of two different cases and literature review].

Elikowski W, Małek M, Flieger J, Baszko A, Fagiewicz A, Wróblewski D.

Kardiol Pol. 2007 May;65(5):565-70. Review. Polish.

9.

[Topical optical beta-adrenergic antagonists and quinidine--a risky combination].

Pianka P, Lazar M, Geyer O.

Harefuah. 1998 Mar 1;134(5):402-3. Review. Hebrew. No abstract available.

PMID:
10909562
10.

Current use of ophthalmic beta blockers.

Gross RL, Pineyro A.

J Glaucoma. 1997 Jun;6(3):188-91. Review. No abstract available.

PMID:
9211143
11.

[Systemic complications of beta-blocking eyedrops. Apropos of 6 cases].

Vinti H, Chichmanian RM, Fournier JP, Pesce A, Taillan B, Fuzibet JG, Cassuto JP, Dujardin P.

Rev Med Interne. 1989 Jan-Feb;10(1):41-4. Review. French.

PMID:
2566193
12.

Cardiovascular and respiratory considerations with pharmacotherapy of glaucoma and ocular hypertension.

Han JA, Frishman WH, Wu Sun S, Palmiero PM, Petrillo R.

Cardiol Rev. 2008 Mar-Apr;16(2):95-108. doi: 10.1097/CRD.0b013e318156ec64. Review.

PMID:
18281912
13.

Beta blockers and the elderly with glaucoma: are we adding insult to injury?

O'Donoghue E.

Br J Ophthalmol. 1995 Sep;79(9):794-6. Review. No abstract available.

14.

[Systemic effects of eyedrops].

Le Jeunne C, Hugues FC, Munera Y, Haas C.

Ann Med Interne (Paris). 1990;141(8):674-7. Review. French. No abstract available.

PMID:
1982605
15.

The safety and efficacy of glaucoma medication in the pediatric population.

Coppens G, Stalmans I, Zeyen T, Casteels I.

J Pediatr Ophthalmol Strabismus. 2009 Jan-Feb;46(1):12-8. Review.

PMID:
19213271
16.

Ophthalmic topics for the non-ophthalmologist.

Lederer CM.

Mo Med. 2005 Jan-Feb;102(1):63-6. Review.

PMID:
15754621
17.

New-onset syncope in older adults: focus on age and etiology.

Roussanov O, Estacio G, Capuno M, Wilson SJ, Kovesdy C, Jarmukli N.

Am J Geriatr Cardiol. 2007 Sep-Oct;16(5):287-94. Review.

PMID:
17786057
18.

[Digital necroses induced by beta-blockers].

Dompmartin A, Le Maitre M, Letessier D, Leroy D.

Ann Dermatol Venereol. 1988;115(5):593-6. Review. French. No abstract available.

PMID:
2904239
19.

[Sneezing. A review of its causation and pathophysiology].

Garcia-Moreno JM.

Rev Neurol. 2005 Nov 16-30;41(10):615-21. Review. Spanish.

20.

[Photic sneeze reflex or autosomal dominant compelling helio-ophthalmic outburst syndrome].

García-Moreno JM.

Neurologia. 2006 Jan-Feb;21(1):26-33. Review. Spanish.

PMID:
16525923

Supplemental Content

Support Center